1. Introduction {#sec0005}
===============

The genus *Pestivirus* of the family *Flaviviridae* consists of four approved species: *Bovine viral diarrhea virus* 1 (BVDV-1), *Bovine viral diarrhea virus* 2 (BVDV-2), *Classical swine fever virus* (CSFV), *Border disease virus* (BDV); and other related viruses such as atypical bovine pestiviruses that have not been assigned to species ([@bib0120]). The pestiviral genome is a single-stranded, positive-sense RNA molecule with a standard size of approximately 12.5 kb ([@bib0015], [@bib0045]). The genome consists of an open reading frame (ORF) flanked by two untranslated regions (UTRs) at the 5′ and 3′ ends. Following translation, the ORF is processed into 11 mature proteins, namely N-terminal protease (N^pro^), capsid protein (C), three glycoproteins (E1, E2, E^rns^), protein of 7 kDa (p7) and five non-structural proteins (NS2-3, NS4A, NS4B, NS5A, NS5B) ([@bib0135]). Glycoprotein E2 is immunodominant in eliciting antibody response to virus infection whereas glycoprotein E^rns^ and non-structural protein NS3 participate in immune response ([@bib0020]). NS3 is conserved antigenically whereas E^rns^ shows less antigenic diversity than E2 ([@bib0055]). Phylogenetic analysis has demonstrated that the atypical bovine pestiviruses are related more closely to the recognized bovine pestivirus species BVDV-1 and BVDV-2 than to any other pestivirus species ([@bib0110], [@bib0105], [@bib0030]).

Bovine pestiviruses may cause subclinical infection or mild to severe diseases, depending on virus strains and host factors. An atypical pestivirus D32/00\_'HoBi' was first detected in a batch of fetal calf serum of Brazilian origin ([@bib0125]) and subsequently similar viruses were detected in batches of fetal bovine serum (FBS) of different origin ([@bib0115], [@bib0100], [@bib0150]). Recent experiments revealed that the atypical bovine pestiviruses may cause clinical signs of the disease similar to those caused by BVDV-1 ([@bib0085], [@bib0040]). Although an atypical pestivirus strain Th/04_KhonKaen was found to cause subclinical infection ([@bib0130], [@bib0070]), another atypical pestivirus was associated with an outbreak of severe respiratory disease in Italy ([@bib0030]). The latter agent was detected subsequently in aborted fetuses ([@bib0035]), which is a reminiscent of a previous report ([@bib0025]).

The economic losses due to BVDV infection may be high. For example, losses are estimated at 10 and 40 million \$ per million calvings at the national level ([@bib0065]). In order to reduce or prevent losses caused by BVDV, national BVDV control programs have been implemented in several countries with great success, especially in Scandinavia ([@bib0090]).

Diagnosis of bovine viral diarrhea (BVD) is based on both direct and indirect detection methods. In indirect detection methods, enzyme-linked immunosorbent assay (ELISA) is used widely for monitoring herd seroprevalence. As an alternative, a microsphere-based immunoassay has been developed ([@bib0145]). This assay is based on the Luminex xMAP technology and it detects NS3 antibodies with high sensitivity and specificity ([@bib0145]). [@bib0005] reported a Luminex multiplex serology assay for the detection of antibodies to four different bovine viruses, namely, bovine herpes virus 1 (BHV-1), parainfluenza 3 virus (PI3V), bovine respiratory syncytial virus (BRSV) and BVDV. In that multiplex assay the use of the recombinant BVDV E2 protein as a potent antigen led to an increase in signal strength.

ELISAs have not been reported for specific detection of the emerging atypical bovine pestiviruses. It has been observed that commercial ELISAs, based on either crude preparation or recombinant antigens of BVDV-1/BVDV-2 are able to detect antibodies against the atypical bovine pestiviruses or their antigens to some extent ([@bib0075]). The glycoprotein E^rns^ of BVDV has also been used as an antigen for serological detection of BVDV ([@bib0060], [@bib0080]) but the cross reactivity against the atypical bovine pestiviruses is still unclear.

The objectives of this study were to produce the E^rns^ protein of an atypical bovine pestivirus using a baculovirus expression system and to evaluate the potential use of this recombinant E^rns^ protein as an antigen in a microsphere immunoassay for the detection of antibodies raised against BVDV-1 and against atypical bovine pestiviruses.

2. Materials and methods {#sec0010}
========================

2.1. RNA extraction, cDNA synthesis, PCR amplification and cloning {#sec0015}
------------------------------------------------------------------

Total RNA was extracted from an isolate of atypical bovine pestivirus Th/04_KhonKaen ([@bib0095]) using TRIzol Reagent (Invitrogen, Carlsbad, CA). cDNA synthesis was primed randomly by 1 μM hexamer in a 20-μl volume using 200 units of Superscript III reverse transcriptase (Invitrogen, Carlsbad, CA). The reaction was performed at 50 °C for 60 min and the enzyme was inactivated at 85 °C for 5 min. The RNA strand of the cDNA was removed by 2 units of *Escherichia coli* RNase H (Invitrogen, Carlsbad, CA) at 37 °C for 20 min. Two microliters of cDNA were used for amplification of the E^rns^ gene region in a 25-μl reaction volume, including 12.5 μl of water, 2.5 μl of 10× buffer, 2 μl of 2.5 mM dNTP mix, 0.5 μl of dimethyl sulfoxide (Sigma, MO, USA), 2.5 μl of 10 μM each primer and 1.25 U *Pfu*Ultra DNA polymerase (Agilent Technologies Inc., Santa Clara, CA). The nucleotide sequences of primers were 5′-GAGAACATAACACAATGGAATTTGAAAG-3′ (forward) and 5′-TGCATGAGCCCCGAACC-3′ (reverse). The thermo profile was 35 cycles of 94 °C for 40 s, 49 °C for 40 s, 72 °C for 40 s. The amplified PCR product (681 bp) was separated on a 1.5% agarose gel. The excised fragment was purified using PCR cleanup system kit (Promega, Co., Madison, WI) and cloned into pFastBac/HBM-TOPO vector (Invitrogen, Carlsbad, CA), and the positive plasmids designed as pFastBacHBM-E^rns^ were verified by DNA sequencing.

2.2. Expression of E^rns^ protein in a baculovirus/insect cell system {#sec0020}
---------------------------------------------------------------------

The plasmid pFastBacHBM-E^rns^ was transformed to MAX Efficiency DH10Bac competent *E. coli* (Invitrogen, Carlsbad, CA) to generate recombinant bacmid, which was further verified based on the phenotypic characteristics and analytical PCR according to manufacturer\'s instructions. One microgram of bacmid DNA and 6 μl of Cellfectin II reagent (Invitrogen, Carlsbad, CA) were used for transfection of 2.4 × 10^6^ *Spodoptera frugiperda* (Sf9) cells. The cells were incubated at 27 °C for 72 h. Sf9 cells were grown in serum free medium Sf-900 II SFM (Invitrogen, Carlsbad, CA). The recombinant viruses were harvested and the virus titer was determined by BacPAK Baculovirus Rapid Titer kit (Clontech Laboratories, Inc., Mountain View, CA) as per instructions of the manufacturer. To optimize the protein expression, a multiplicity of infection (MOI) value of 0.5 and 1 was used to infect cells at a density of 2 × 10^6^/ml. After 24 h post infection, 0.5% FBS was added and the cells were collected at 48, 72 and 96 h post infection and centrifuged at 800 ×  *g* for 5 min. Pellets were washed with 1 ml phosphate buffered saline (PBS) and stored at −20 °C if not used immediately. To analyze proteins, 75 μl of lysis buffer (200 mM Tris, 20% glycerol, 5 mM ethylenediaminetetraacetic acid (EDTA), 4% sodium dodecyl sulfate (SDS), 50 mM dithiothreitol (DTT), 6 units of benzonase) was added to the cell pellet and incubated at 4 °C for 30 min. The pellet and supernatant were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot using anti-His monoclonal antibody (Sigma, St. Louis, MI).

2.3. Purification of the recombinant E^rns^ protein {#sec0025}
---------------------------------------------------

One milliliter of cell lysis buffer (25 mM Hepes, pH 7.4, 100 mM NaCl, 1% Triton X-100, 1× protease inhibitor) was added to 1.2 × 10^7^  cells and incubated on ice for 45 min. The cells were sheared by brief sonication and soluble proteins were recovered in the supernatant following ultra-centrifugation at 40,000 ×  *g* for 30 min at 4 °C. The His-Trap Chelating HP column (GE Healthcare, Uppsala, Sweden) was equilibrated with 10 column volumes of buffer A (50 mM Hepes, pH 7.4, 500 mM NaCl, 10 mM Imidazole). After loading the sample, the column was washed with 10 volumes of buffer B (50 mM Hepes, pH 7.4, 400 mM NaCl, 30 mM Imidazole). The protein was eluted from the column with 100, 300 and 500 mM of imidazole, respectively. The elution fractions were concentrated with a 10-kDa molecular weight cut-off Amicon Ultra-4 Centrifugal Filter Devices (Millipore Ireland B.V., County Cork, Ireland).

2.4. Microsphere immunoassay {#sec0030}
----------------------------

Coupling of the recombinant E^rns^ protein to carboxylated microspheres (Luminex Cooperation, Austin, TX) was mediated by 1-ethyl-3-3-dimethylaminopropyl carbodiimide (EDC) (Pierce, Rockford, IL), as described previously ([@bib0145]). The optimal amount of the protein, dilution of the serum, concentration of secondary antibody and conjugate, and blocking solutions were determined experimentally. The beads were resuspended in 200 μl of PBS--TBN (PBS, 0.1% bovine serum albumin (BSA), 0.02% Tween-20, 0.05% Azide, pH 7.4) and stored at 4 °C in darkness. Coupling reaction was confirmed by testing a mix of two E^rns^ monoclonal antibodies (MAbs) (WS363 and WS433, AHVLA, UK) on a Luminex 200 analyzer, as described previously ([@bib0145]).

The immunoassay was performed in 96-well plates. The microspheres coupled with the recombinant E^rns^ protein were resuspended in PBS with 1% BSA and 50 μl of microspheres were transferred to each well of the plates. Fifty microliter of sera and 50 μl of PBS with 1% BSA were added to the respective wells and incubated at 37 °C for 30 min on a plate shaker. The microspheres were washed twice with PBS containing 1% BSA using a HydroFlex™ microplate washer (Tecan Group Ltd., Männedorf, Switzerland). Thereafter, 50 μl of 2 μg/ml biotinylated anti-bovine IgG (Jackson ImmunoResearch, West Grove, USA) in PBS with 1% BSA were added to each well and incubated for another 30 min. Following washing as before, 50 μl of 10 μg/ml streptavidin-R-phycoerythrin conjugate (ProZyme, Inc., Hayward, CA) in PBS with 1% BSA were added to each well and incubated at 37 °C for 30 min on the plate shaker. After washing twice, the microspheres were resuspended in 100 μl of PBS with 1% BSA and analyzed by the Luminex 200 analyzer. Median fluorescence intensity (MFI) was calculated based on the measurement of 100 beads per sample. Receiver operating characteristic (ROC) analysis of the microsphere immunoassay and ELISA were performed using Medcalc software (MedCalc Software, Mariakerke, Belgium) to determine a cut-off value of the microsphere immunoassay.

2.5. Optimization of microsphere immunoassay {#sec0035}
--------------------------------------------

Several parameters of the immunoassay were optimized, including dilution of the serum, concentration of anti-bovine IgG/streptavidin, number of coupled beads and different blocking solutions.

2.6. Bovine serum samples {#sec0040}
-------------------------

A total of 596 serum samples were evaluated in this study. These included 24 batches of FBS from ten different commercial suppliers ([@bib0150]), 306 bovine sera that were collected recently in Sweden, 246 bovine sera that had been described previously ([@bib0145]), and 20 samples that were collected from an experimental infection with a BVDV-1 strain Hon916, the atypical bovine pestivirus strain Th/04_KhonKaen, both viruses, or mock infection with cell culture medium ([@bib0085]). The FBS (*n*  = 24) and recent collection of bovine sera (*n*  = 306) were tested for the presence of antibodies against BVDV by a commercial ELISA kit (Svanova Biotech AB, Uppsala, Sweden) according to the manufacturer\'s instruction. The kit had a sensitivity of 100% and a specificity of 98.2% compared with virus neutralization test using BVDV-1 strains (Svanova Biotech AB, Uppsala, Sweden).

3. Results {#sec0045}
==========

3.1. Expression and purification of the recombinant E^rns^ protein {#sec0050}
------------------------------------------------------------------

The expression of the recombinant E^rns^ protein in Sf9 cells was driven by a strong polyhedrin promoter of *Autographa californica* multiple nuclear polyhedrosis virus (AcMNPV). The expression conditions at 72 h post transfection and at an MOI of 1 were found optimal and the recombinant E^rns^ protein (around 40 kDa) was detected by Western blot using anti-His MAb ([Fig. 1](#fig1){ref-type="fig"}A). By affinity chromatography, the E^rns^ protein was eluted from the Ni^2+^ column with 300 mM imidazole ([Fig. 1](#fig1){ref-type="fig"}B). To verify the antigenicity of the recombinant E^rns^ protein, a BVDV positive serum was used as primary antibody. As shown in [Fig. 1](#fig1){ref-type="fig"}C, the recombinant E^rns^ protein reacted well with the BVDV positive serum, indicating that the recombinant protein maintained its antigenicity.Fig. 1Western blot analysis of the E^rns^ protein using anti-His MAb (A and B) or positive serum (C) as primary antibody. (A) Expression of the E^rns^ protein. Lane 1: Sf9 cell lysate, lane 2: 48 h cell lysate, lane 3: 72 h cell lysate, lane 4: 96 h cell lysate. (B) Purification of the E^rns^ protein, lane 1: sonication supernatant, lane 2: ultacentrifuge supernatant, lane 3: flowthrough, lane 4: wash fraction, lane 5: eluted fraction (300 mM imidazole), lane 6: concentrated protein (10 μg). (C) BVDV serum was used as primary antibody to verify antigenicity of the E^rns^ protein, lane 1: eluted fraction (300 mM imidazole), lane 2: concentrated protein (10 μg).

3.2. Optimization of the microsphere immunoassay {#sec0055}
------------------------------------------------

As a first step, the amount of the recombinant E^rns^ protein was determined for coupling microspheres. To test coupling efficiency, a mixture of two MAbs (WS363 and WS433) and 4 μg/ml of anti-mouse IgG conjugated with R-phycoerythrin were used in the immunoassay. Fifty micrograms of the recombinant E^rns^ protein were found optimal for coupling 1.2 million microspheres, which gave an MFI value of around 11,000, whereas further increasing E^rns^ protein to 80 μg had lower MFI values ([Fig. 2](#fig0010){ref-type="fig"}A). A 5-fold dilution of sera was found optimal ([Fig. 2](#fig0010){ref-type="fig"}B).Fig. 2Optimization of the microsphere immunoassay. (A) Selection of coupled recombinant E^rns^ to microsphere. (B) Blocking of Sf9 cell protein binding antibodies in 5-fold diluted bovine sera, the MFI value are average values of four positive and negative sera. (C--F) Selection of blocking agents, optimal serum dilution, amount of detection antibody and microspheres according to mean MFI value of four positive and four negative sera. Light-shaded columns indicate the optimal conditions for the immunoassay.

To reduce unspecific binding to the recombinant protein, four different blocking solutions, PBS with 1% BSA, PBS with 1% Triton X-100, PBS with 0.05% Tween-20, and PBS with 5% milk were tested in four pairs of positive and negative samples. Two solutions (PBS with 1% BSA and PBS with 5% milk) had the lowest MFI value for the negative serum while the MFI value for the positive sample remained high ([Fig. 2](#fig0010){ref-type="fig"}C). Pre-incubation of sera with Sf9 cell lysate (27 mg/ml) also helped to reduce the unspecific binding effectively. Incubation of 60 μg Sf9 cell lysate with 50 μl 5-fold diluted serum at room temperature for 30 min was most successful in reducing unspecific binding ([Fig. 2](#fig0010){ref-type="fig"}D). The optimal amount of secondary antibody was 2 μg/ml of biotinylated anti-bovine IgG when reacted with 10 μg/ml of streptavidin-R-phycoerythrin conjugate ([Fig. 2](#fig0010){ref-type="fig"}E). Finally, 600 microspheres were found sufficient for antibody detection ([Fig. 2](#fig0010){ref-type="fig"}F).

3.3. Comparison of microsphere immunoassay and ELISA {#sec0060}
----------------------------------------------------

Once optimized, the microsphere immunoassay was evaluated by testing a total of 596 serum samples, which were tested by ELISA either in previous studies ([@bib0145], [@bib0085]) or in this study. Based on the non-parametric ROC analysis, the cut-off MFI value of the microsphere immunoassay was set to 2800. Under this cut-off value, 369 samples were found negative and 227 samples were positive. The positive samples included 212 BVDV-1 clinical samples, a total of 15 samples originated from the experimental infection with atypical bovine pestivirus (*n*  = 5), BVDV-1 (*n*  = 5), and both BVDV-1 and atypical bovine pestivirus (*n*  = 5). The MFI values for negative samples were between 115 and 1822 with a mean value of 357, while the values for the positive samples ranged from 3812 to 26,453 with a mean value of 13,727. The immunoassay results matched the ELISA results, showing 100% sensitivity and 100% specificity relative to ELISA. The confidence interval (CI) for sensitivity was 98--100%, and the CI for specificity was 99--100%.

4. Discussion {#sec0065}
=============

This study described expression and purification of the E^rns^ glycoprotein of an atypical bovine pestivirus and subsequent evaluation of the recombinant protein as the antigen in a microsphere immunoassay for the detection of antibodies against BVDV-1 and atypical bovine pestivirus. While it is evident that atypical bovine pestiviruses cause respiratory disease and abortion, there is a need for a serological assay for the specific detection of antibodies against this atypical pestivirus. ELISA that is based on E2 and NS3 are shown to cross react with antibodies against atypical pestiviruses ([@bib0085], [@bib0010]), whereas there is no report of detection of antibodies against atypical pestivirus by an E^rns^ ELISA. Therefore, the E^rns^ glycoprotein was selected as the antigen in our microsphere immunoassay. The test was evaluated for the detection of specific antibodies against BVDV-1. Also, possibility of detection of specific antibodies against atypical bovine pestivirus was investigated. According to obtained results, this test has the potential to be implemented in diagnosis of the disease caused by atypical bovine pestiviruses.

Production of recombinant viral protein as the antigen is an important step in developing this microsphere immunoassay. To maintain proper post-translational modifications of the E^rns^ protein and, likely to maintain its antigenicity, a baculovirus/insect cell system was exploited in this study, resulting in high MFI values for the positive samples. In the Luminex assay described by [@bib0005], an MFI value close to 30,000 was obtained for the 1/450 dilution of a positive sample when recombinant E2 protein was used as the antigen, whereas it was only around 2000 for the same diluted sample when crude viral lysate was used as the antigen. As pointed out by [@bib0050], using a recombinant protein as an antigen in a multiplex Luminex assay has improved significantly sensitivities (94% and 100%, respectively) and specificities (100% and 95%, respectively) than using bacterial membrane extracts (78% sensitivity and 65% specificity).

Various blocking agents were tested to reduce unspecific binding. It was found that PBS containing 1% BSA or 5% milk was able to reduce the unspecific binding effectively. However, blocking with PBS containing 5% milk in the immunoassay created certain technical problems: it clogged the needle in the Luminex analyzer such that the probe had to be cleaned four or five times during analysis. The microspheres were also likely to be aggregated and covered by the milk, and were lost during washing steps. Therefore, it took the analyzer longer time to count 100 beads per sample and the test could fail completely. The PBS containing 1% BSA worked well for some samples but high MFI values were also observed in several negative samples. As the microspheres itself gave neglect MFI values, it is likely that even in the purified protein there were still some impurities that caused the unspecific binding to bovine antibodies. To reduce the unspecific binding, sera were incubated with Sf9 cell lysate before being tested in the immunoassay, which brought down MFI values for the negative samples whereas the MFI values for the positive samples were not affected. Cell lysate has been used to reduce unspecific binding in a Luminex serological assay ([@bib0140]).

The diagnostic performance of the microsphere immunoassay was compared to that of commercial BVDV antibody ELISA by testing a large panel of 596 serum samples. Both results matched 100%. Two serum samples, which had been tested negative by ELISA but positive by a blocking microsphere immunoassay targeting NS3 antibodies ([@bib0145]), remained negative in this E^rns^ immunoassay. It seemed likely that the two serum samples were either truly negative or very weak positive that was only detected by the blocking immunoassay. While 15 serum samples from all three infected groups were tested positive, a slight difference in the MFI values was observed. The highest MFI value (average) was 21,956 for the sera against atypical pestivirus, where the viral E^rns^ protein was the antigen; the lowest MFI value (average) was 17,818 for the BVDV-1 sera that were heterologous to the antigen; and 20,471 for the sera of the mixed infection. Interestingly, when the E^rns^ protein was replaced by that of BVDV-1 strain CP7, the average MFI values of these three groups changed, with the highest (22,915) for the homologous sera (BVDV-1) and the lowest (17,425) for the heterologous sera (atypical pestivirus) and middle value (20,715) for the mixed infection. More studies are needed in order to investigate whether this correlation is consistent or it is just a coincidence. Furthermore, the immunoassay could be expanded readily for the simultaneous detection of antibodies against multiple bovine viruses in the Bovine Respiratory and Enteric Disease (BRD and BED, respectively) complexes, such as bovine coronavirus, bovine respiratory syncytial virus, and bovine parainfluenza-3 virus.

5. Conclusion {#sec0070}
=============

The recombinant E^rns^ protein produced in the baculovirus/insect cell system maintained its antigenicity. The E^rns^ microsphere immunoassay was able to detect antibodies against bovine viral diarrhea viruses with performance similar to commercial ELISAs. Thus, the microsphere immunoassay, using the recombinant E^rns^ protein of an atypical bovine pestivirus, offers a powerful novel alternative to the current diagnostic methods for bovine viral diarrhea and related diseases. This microsphere immunoassay platform opens new possibilities for the rapid and complex diagnosis of respiratory and enteric diseases, with great multiplexing potential and flexibility.
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